The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Non-Small-Cell Lung Carcinoma|Malignant Melanoma|Renal Cell Carcinoma|Triple-Negative Breast Cancer
Interventions: DRUG: Checkpoint Inhibitor, Immune
Sponsor: VastBiome